Drugs / Aconite pain oil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT06186479 | Mar 2024 → Aug 2027 expected | chemotherapy-induced neuropathy | WALA Heilmittel GmbH | Recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Aconite pain oil | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06186479 ↗ |
| Route | Topical | “Participants apply 6 ml oil topically 2 times per day” NCT06186479 ↗ |